MannKind Corp. (MNKD)
4.075
-0.08
(-1.81%)
USD |
NASDAQ |
Aug 24, 16:00
4.075
0.00 (0.00%)
After-Hours: 20:00
MannKind Enterprise Value : 1.611B for Aug. 21, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| August 21, 2026 | 1.611B |
| August 20, 2026 | 1.645B |
| August 19, 2026 | 1.687B |
| August 18, 2026 | 1.587B |
| August 17, 2026 | 1.534B |
| August 14, 2026 | 1.518B |
| August 13, 2026 | 1.481B |
| August 12, 2026 | 1.518B |
| August 11, 2026 | 1.515B |
| August 10, 2026 | 1.543B |
| August 07, 2026 | 1.599B |
| August 06, 2026 | 1.531B |
| August 05, 2026 | 1.596B |
| August 04, 2026 | 1.552B |
| August 03, 2026 | 1.503B |
| July 31, 2026 | 1.537B |
| July 30, 2026 | 1.599B |
| July 29, 2026 | 1.518B |
| July 28, 2026 | 1.537B |
| July 27, 2026 | 1.549B |
| July 24, 2026 | 1.605B |
| July 23, 2026 | 1.531B |
| July 22, 2026 | 1.515B |
| July 21, 2026 | 1.580B |
| July 20, 2026 | 1.559B |
| Date | Value |
|---|---|
| July 17, 2026 | 1.574B |
| July 16, 2026 | 1.577B |
| July 15, 2026 | 1.593B |
| July 14, 2026 | 1.528B |
| July 13, 2026 | 1.577B |
| July 10, 2026 | 1.593B |
| July 09, 2026 | 1.608B |
| July 08, 2026 | 1.642B |
| July 07, 2026 | 1.633B |
| July 06, 2026 | 1.649B |
| July 02, 2026 | 1.726B |
| July 01, 2026 | 1.580B |
| June 30, 2026 | 1.645B |
| June 29, 2026 | 1.613B |
| June 26, 2026 | 1.582B |
| June 25, 2026 | 1.517B |
| June 24, 2026 | 1.489B |
| June 23, 2026 | 1.517B |
| June 22, 2026 | 1.504B |
| June 18, 2026 | 1.520B |
| June 17, 2026 | 1.514B |
| June 16, 2026 | 1.498B |
| June 15, 2026 | 1.538B |
| June 12, 2026 | 1.433B |
| June 11, 2026 | 1.461B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| United Therapeutics Corp. | 19.24B |
| ACADIA Pharmaceuticals, Inc. | 4.195B |
| Gilead Sciences, Inc. | 202.61B |
| Vertex Pharmaceuticals, Inc. | 132.96B |
| Ocugen, Inc. | 459.21M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -19.03M |
| Revenue (Quarterly) | 109.37M |
| Total Expenses (Quarterly) | 128.41M |
| EPS Diluted (Quarterly) | -0.0616 |
| Gross Profit Margin (Quarterly) | 69.00% |
| Profit Margin (Quarterly) | -17.40% |
| Earnings Yield | -3.48% |
| Operating Earnings Yield | 1.05% |
| Normalized Earnings Yield | -2.307 |